DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The DNA damage response pathway is crucial for chemoresistance in chronic lymphocytic leukemia (CLL).
• TP53 and ATM alterations significantly impact prognosis in CLL patients.
• Understanding the p53 axis function is vital for predicting treatment response.

Purpose of the Study:

• To investigate the functional response of the p53 axis in primary CLL samples.
• To evaluate the detectability of p53 defects using functional assays compared to genetic methods.
• To assess the impact of TP53 aberrations and deletions on p53 and p21 responses.

Main Methods:

• Primary CLL samples were analyzed for p53 and p21 responses to irradiation.
• Flow cytometry (FACS) and reverse transcription-polymerase chain reaction (RT-PCR) were employed.
• Detection of 17p deletion, TP53 mutations, and 11q deletion was performed.

Main Results:

• Functional assays identified p53 defects missed by genetic testing (FISH, TP53 mutational analysis) in some cases, particularly those with small TP53-mutated clones.
• Distinct p53/p21 response patterns were observed in cases with 17p deletion or TP53 mutation.
• Impaired p53 and p21 induction in 11q-deleted samples suggests a gene-dosage effect for ATM.

Conclusions:

• Detectability of p53 defects is influenced by clonal heterogeneity and sample purity.
• Functional p53 assays offer complementary detection of aberrations not identified by standard genetic methods.
• Clinical utility of functional p53 testing requires validation through clinical trials.